Symeres

Symeres is a CDMO that turns small-molecule ideas into clinical candidates, working across medicinal chemistry, in vitro biology, ADME-Tox and process chemistry to move compounds forward even when biology doesn't behave as expected. By keeping discovery, development and manufacturing connected and sharing results quickly, the company reduces risk and helps clients adapt and keep moving, supporting hit finding, hit-to-lead, lead optimization, preclinical development and clinical development.